VATICAN CONFERENCE HIGHLIGHTS CONCERNS OVER USING PSYCHOACTIVE DRUGS ON CHILDREN WORLDWIDE - JUNE 2013 - "Is the use of prescription drugs effective for treating emotional and behavioral problems in children? Is it even safe?" a quote from the Vatican's own publicity.

 

THE VATICAN ADDRESSES ANOTHER HUGE WORLDWIDE 
CHILD 
SAFEGUARDING ISSUE

Click on link below to hear Radio Vatican interview with Dr Joanna Moncrieff + DrPat Bracken

  http://en.radiovaticana.va/news/2013/06/14/vatican_conference:_why_is_prescription_of_psychotropic_drugs_t/en1-701273


Vatican Radio

Why have psychiatric medications such as anti-depressants emerged as the first line of treatment for young people and children suffering from mental health disorders? And are this rising prescription rates justified by the clinical trial evidence? These are the main questions being debated by renowned psychiatrists and other health experts from around the world who are attending a 2-day conference in the Vatican sponsored by the Pontifical Council for Healthcare Workers. 

Among the participants at the conference is Dr Joanna Moncrieff, a practicing consultant psychiatrist in London who spoke to Vatican Radio’s Susy Hodges

Asked about her reaction to the massive increase in the prescription of psychotropic drugs over the past two decades, Dr Moncrieff says she is "worried" about this trend as she believes it is "the result of a fundamental misunderstanding about the nature of these drugs."

"We're prescribing mind-altering substances to people to suppress and subdue their emotions and their behaviour" and she points the finger of blame for much of this trend at the pharmaceutical industry who, she says, "have been persuading people that they need to take chemicals in order to function normally."

Although there are no overall statistics for the number of people taking psychotropic drugs, Dr Moncrieff says "the number of prescriptions of anti-depressants in the UK has risen by 400 percent since the early 1990's." In her view, it 's now become "a vicious circle" with people as a result of seeing the advertising and promotion of these medications on the internet going to their doctor and "expecting drugs" for dealing with their emotional problems and the doctors giving them these drugs. She hopes this conference in the Vatican "will give people a better understanding of what drug treatment for mental disorders really constitutes." She also hopes it will "encourage people to seek alternative ways to manage distressing emotions and distressing behaviours."

Another participant at the conference in the Vatican who spoke to Susy Hodges is Dr Pat Bracken, a psychiatrist from West Cork in Ireland.

Asked why there has been a large increase in the number of psychotropic drugs being prescribed to young people, Dr Bracken says it's a "complicated picture with no single answer" although he agrees with Dr Moncrieff that the increase in prescription rates is "massive" and says "a lot of companies (in the pharmaceutical industry) made a lot of money out of this development."

He goes on to explain how these pharmaceutical companies have helped "nurture an environment within psychiatry where drug treatments are sometimes seen as the first and sometimes as the only response to mental distress."

Dr Bracken, however, believes that it's not just "the profit motive" that has brought about this situation but it also reflects changes in our contemporary society such as the rise in secularisation. Drawing on his own family's experience, he says that in the past people's religious faith sustained them" and helped them "to overcome their problems and sufferings." He goes on to talk about how many of these psychotrophic drugs have "very serious-side effects" and advocates what he calls a "recovery approach" to help people suffering from mental disorders to use their own initiatives and their own support networks to find "their own paths" towards healing.

Listen to the extended interviews with Dr Moncrieff and Dr Bracken

·          

·          

·          

·         

Rome, June 10, 2013

Is the use of prescription drugs effective for treating emotional and behavioral problems in children? Is it even safe?

Experts will attempt to answer these questions during a Vatican conference titled "The Child as a Person and as a Patient: Therapeutic Approaches Compared." Organized by the Pontifical Council for Health Care Ministry, the conference, which will run this weekend from June 14-15, will explore the harmful effects of over-prescribing psychotropic drugs to children and pregnant mothers.

Psychiatric medications have emerged as a first line of treatment for emotional and behavioral problems in children, while the use of psychosocial intervention has declined. However, Marcia Barbacki, an occupational therapist and one of the organizers of the conference, argues that global prescription rates of psychotropic drugs are not justified according to clinical trial evidence. "We want to share accurate data and provide solutions at multiple levels that value life, family and Church, and promote ethical research in health care," she told ZENIT. "It is time to no longer accept prescriptive practices that do not follow the evidence and increasingly put children at perilous risk for serious health consequences, dependence, and disability."

There are a host of side effects from many of these drugs, Barbacki said. For instance:

·         "The stimulants now have warnings of sudden 

cardiac arrest and suicide. 

Stimulants stunt physical growth 1 cm and 2 kg per 

year."

·         "The antipsychotics contribute to diabetes, obesity, tardive dyskinesia, neuroleptic malignant syndrome, and early death. There is no scientific evidence supporting effectiveness.

·         "The antidepressants have warnings for suicidal behavior, manic behaviors, birth defects, and stunted growth and no scientific evidence of their effectiveness.

"Given the clinical trial data examination,  outcomes and risks," she said, speakers at the conference "will be recommending that psychosocial options should be the first line of intervention."

The parents of children with behavioral or emotional problems, Barbacki continued, "need to know that there are multiple psychosocial options with the data demonstrating the superior short and long term outcomes of these non-pharmacological approaches that honor family, culture, faith, Church and spirituality."

"The data supports the therapeutic relationship and the compassion inherent in that relationship for both short and long term outcomes. This is consistent with the model of the Good Shepherd," she said.

"It is our ultimate hope that this conference will actually make a difference in the lives of children who find themselves in harm’s way, children who are often harmed even more by the treatments they receive… It is our hope that this issue can continue to be studied formally with follow-up meetings like this conference," she said.

Experts, like Harvard psychologist Irving Kirsch, author of The Emperor’s New Drugs, say that pharmaceutical companies have contributed to the increase of psychotropic drugs being prescribed to children. "They have done so by withholding data from publication, by publishing only the most successful studies, and even then distorting the data. The data as presented in publications make these medications look better than the data submitted to the FDA. So prescribing physicians have not been provided with the information they would need to make informed decisions."

Speaking with ZENIT, Kirsch, who will be one of the keynote speakers at the conference, explained how he and his colleagues analyzed the data which drug companies sent to the FDA when they applied for approval of antidepressants. "My analyses of these data indicated that the drugs were little better than placebos. The difference between drug and placebo for most patients was so small as to be clinically meaningless. We also collaborated in an analysis comparing the outcomes of different treatments for depression. We found that psychotherapy, physical exercise, and acupuncture were as effective as antidepressants in combating depression."

Although antidepressants are not very effective in treating depression, he said, they nevertheless come with risks."Antidepressants are active chemicals with serious side effects and health risks. They increase suicidality in children, and their use has been associated with increased risk of becoming depressed again in the future."

Even though Dr. Kirsch does not recommend psychotropic drugs for children, he says there is still hope for children struggling with these disorders. "There are psychotherapists who are trained in working with children.  

"Psychotherapy is an excellent 

alternative."